Chengdu Kanghong Pharmaceutical Group Co., Ltd

The company was founded in 1996, has advanced R&D centers and standard industrial production bases, and a marketing network all over the country. The company's main business is R&D, production and sales of pharmaceuticals (including biological products, proprietary Chinese medicines, chemicals) and medical devices (mainly ophthalmic medical devices). The main products are: compacipril ophthalmic injections, hepatic relief capsules, Songling Xuemaikang capsules, Qiuoxin capsules, cholestasis capsules, Yiqing capsules, venlafaxine hydrochloride sustained-release tablets, aripiprazole oral solution, mosapride citrate tablets, moxapride citrate tablets, dzopiclone tablets, etc. Corporate honors include “Innovative Drug with the Most Clinical Value”, the 5th “China Industry Award”, and the China Patent Gold Award.